PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

23 hedge funds and large institutions have $14.8M invested in Protalix BioTherapeutics in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 10 closing their positions.

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
1
Reduced
5
Closed
10
Calls
$378K
Puts
$343K
Net Calls
+$35K
Net Calls Change
-$530K

Top Buyers

1
BCM
1
Burrage Capital Management
Massachusetts
$8.97M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$202K
3
Group One Trading
3
Group One Trading
Illinois
$183K
4
Capstone Investment Advisors
4
Capstone Investment Advisors
New York
$80K
5
Wolverine Trading
5
Wolverine Trading
Illinois
$38K

Top Sellers

1
HCM
1
Highbridge Capital Management
New York
$0
2
PF
2
Phoenix Financial
Israel
$0
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$0
4
KCM
4
Kennedy Capital Management
Missouri
$0
5
UOC
5
UBS O'Connor
Illinois
$544K
Name Holding Trade Value Shares
Change 		Shares
Change %
KCM
26
Kennedy Capital Management
Missouri
– -$577K -149,151 Closed
EMG
27
ETF Managers Group
New Jersey
– -$397K -101,768 Closed
MWPCG
28
Measured Wealth Private Client Group
New Hampshire
– -$148K -38,116 Closed
Simplex Trading
29
Simplex Trading
Illinois
– -$69K -18,043 Closed
VanEck Associates
30
VanEck Associates
New York
– -$35K -9,096 Closed
BlackRock
31
BlackRock
New York
– -$24K -6,284 Closed
1
2